Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab.
A case of neuromyelitis optica misdiagnosed as cervicogenic headache.
Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome.
Mobility, Walking And Physical Activity In Persons With Multiple Sclerosis.
Statins in neurological disorders: An overview and update.
Validating archetypes for the Multiple Sclerosis Functional Composite.
New analysis indicates that Novartis drug Gilenya shows significant early effect on reducing brain volume loss at 6 months
Volumetric MRI assessment of brain and spinal cord in finnish twins discordant for multiple sclerosis.
Effects of fatigue on balance and mobility in subjects with multiple sclerosis: a brief report.
Higher susceptibility to experimental autoimmune encephalomyelitis in Muc1-deficient mice is associated with increased Th1/Th17 responses.
Improving adherence to injectable disease-modifying drugs in multiple sclerosis.
Serum uric acid level in patients with relapsing-remitting multiple sclerosis.
Self-reported use of the upper limbs related to clinical tests in persons with multiple sclerosis.
A case of hereditary diffuse leukoencephalopathy with axonal spheroids caused by a de novo mutation in CSF1R masquerading as primary progressive multiple sclerosis.
FLAIR*: A Combined MR Contrast Technique for Visualizing White Matter Lesions and Parenchymal Veins.
Intrathecal baclofen pump for spasticity: an evidence-based analysis.
[Optic neuritis and optic ischemic neuropathy: the problem of differential diagnosis].
Assessment set for evaluation of clinical outcomes in multiple sclerosis: psychometric properties.
Stress caused adverse entanglement of the nervous and autoimmune systems: A case for MS.
Adherence to monthly online self-assessments for short-term monitoring: a 1-year study in relapsing-remitting multiple sclerosis patients after start of disease modifying treatment.
Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
Modulation of BV-2 microglia functions by novel quercetin pivaloyl ester.
Literature Commentary.
Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder.
Long-term endurance exercise improves aerobic capacity in patients with relapsing-remitting Multiple Sclerosis: Impact of baseline fatigue.
Pages
« first
‹ previous
…
431
432
433
434
435
436
437
438
439
…
next ›
last »